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Abstract  
Chromatin plasticity is thought to be fundamental to the pluripotency of embryonic stem cells.  
Hmgn proteins modulate chromatin structure and are highly expressed during early development 
and in neural stem/progenitor cells of the developing and adult brain. Here, we show that loss of 
Hmgn1 or Hmgn2 in pluripotent embryonal carcinoma cells leads to increased levels of spontaneous 
neuronal differentiation. This is accompanied by the loss of pluripotency markers and increased  
expression of the pro-neural transcription factors Neurog1 and Ascl1. Neural stem cells derived from 
these Hmgn-knockout lines also show increased spontaneous neuronal differentiation and Neurog1 
expression. The loss of Hmgn2 is associated with the disruption of active chromatin states at specific 
classes of gene. The levels of H3K4me3, H3K9ac, H3K27ac and H3K122ac are considerably reduced at 
the pluripotency genes Nanog and Oct4, which impacts transcription. At endodermal/mesodermal 
lineage-specific genes, the loss of Hmgn2 leads to a switch from a bivalent to a repressive chromatin 
configuration. However, at the neuronal lineage genes Neurog1 and Ascl1, no epigenetic changes 
are observed and their bivalent states are retained. We conclude that Hmgn proteins play important 
roles in maintaining chromatin plasticity in stem cells, and are essential for maintaining stem cell 
identity and pluripotency.  
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Introduction 
The chromatin landscape of embryonic stem cells has distinct characteristics that are believed to 
confer increased plasticity and thus contribute to the maintenance of the pluripotent state (1). 
Plasticity is achieved through a range of mechanisms, including bivalent epigenetic states (2), more 
numerous DNaseI hypersensitive sites (3), increased levels of active transcriptional marks, fewer and 
less condensed heterochromatin loci, and hyperdynamic binding of major architectural proteins such 
as the linker histones (4).  
Hmgn (High Mobility Group Nucleosome binding) family members are chromatin architectural 
proteins that influence local and global chromatin structure, and have wide ranging effects on gene 
expression (5). They are devoid of enzymatic activity, and bind to the nucleosome or core particle of 
chromatin without specificity for the underlying DNA sequence. The two most abundant and well-
studied Hmgn isoforms are Hmgn1 and Hmgn2. The five Hmgn family members share a general 
structure, consisting of a conserved positively charged nucleosome binding domain (NBD) that 
specifically targets the nucleosome and constitutes the hallmark of the family, a bipartite nuclear 
localisation signal, and a variable negatively charged C-terminal or regulatory domain (RD) (6).  
Hmgn proteins have been shown to modulate chromatin structure in a variety of ways. They can 
alter the ability of histone acetylases and kinases to modify core histone N-terminal tails (7-9) and 
have been shown to inhibit the activity of chromatin remodelling complexes (10). They also inhibit 
the interaction of linker histones with chromatin, which can lead to decompaction and reduced 
EZH2-mediated methylation of histone H3K27 (11,12). They have also been shown to increase the 
recruitment of certain transcription factors to chromatin (13). 
Chromatin immunoprecipitation studies from several labs have shown that Hmgn proteins do not 
tend to be highly enriched at individual genes (9,14-16). This is consistent with observations that 
Hmgns do not have any specificity for the underlying DNA sequence, and that their binding to 
chromatin is transient and dynamic, and with continuous exchange from one nucleosome to another 
(17). However, ChIP-seq studies by the Bustin lab have shown that Hmgn1 and Hmgn2 are enriched 
at DNase I hypersensitivity sites (DHSs) in several mammalian cell lines (3,18-20). DHSs constitute 
chromatin accessible domains located at transcriptional regulatory regions, such as promoters and 
enhancers, and are considered to be a hallmark of genes poised or activated for transcription. Cells 
lacking both Hmgn1 and Hmgn2 exhibit a reduction in the number and the intensity of the DHSs in 
mouse embryonic fibroblasts and mouse embryonic stem cells (ESCs) (19,20).   
The generation of Hmgn variant-specific knockout mice in the last decade has provided considerable 
insights into the relevance of these proteins at the cellular and organism level. In general, these mice 
are viable and do not present strong phenotypes. Nevertheless, variant-specific phenotypic 
alterations have been reported. For example, Hmgn1-/- mice exhibit increased tumorigenicity and 
impaired DNA damage response (21), whereas Hmgn2-/- mice show some alterations in energy 
metabolism (19). Analyses of transcriptional changes in cells and tissues derived from the genetically 
modified mice indicate that the absence of one or two Hmgn variants does not dramatically modify 
the pre-existing transcriptional profile (3,12,19,20). However, there are significant changes in the 
levels of many mRNA transcripts, which indicates that the general process of transcription is altered, 
and accounts for the Hmgn knockout mouse phenotypes mentioned above. These experiments led 
to the working hypothesis that the Hmgns fine tune an already established expression profile, and 
ensure the appropriate cellular response to external and internal cues required for proper organism 
functioning. 
During development, Hmgn1 and Hmgn2 are highly abundant in embryonic tissues, and then are 
progressively down regulated as differentiation proceeds, remaining at lower levels in fully 
differentiated tissues (22). This decreasing expression pattern has been observed during 
erythropoiesis, myogenesis, and chondrogenesis, and seems to be essential, since Hmgn1 
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overexpression inhibits normal cellular differentiation (15,23,24). Although fully differentiated cells 
have lost substantial amounts of Hmgn proteins, many tissue-specific stem cells and transient 
amplifying precursors retain high levels of these proteins (22,25).  
In the mouse brain, Hmgn1 and Hmgn2 mRNAs are highly expressed in the dentate gyrus of the 
adult hippocampus (3), which is a well characterised neurogenic niche where neural stem cells 
(NSCs) reside and undergo active neurogenesis. A role for Hmgn proteins in NSCs is supported by the 
observation that adult Hmgn1-/- mice exhibit a reduction in Nestin-positive cells in the sub-
ventricular zone (3). Moreover, Hmgns are required for proper differentiation of NS cells into 
astrocytes and oligodendrocytes, since Hmgn knockdown interferes with the neuron to glia 
transition, and the lack of both Hmgn1 and Hmgn2 leads to down-regulation of Olig1 and Olig2 and 
defects in oligogenesis (12,26). Defects in neural stem cell differentiation could be a contributing 
factor to the neurological defects observed in Hmgn1-/- and double knockout Hmgn1-/-Hmgn2-/- mice 
(12,27). Together these data suggest a role for Hmgn proteins in tissue-specific stem cell biology and 
differentiation, especially among the neural lineage. 
In this study, we have investigated the role of Hmgn1 and Hmgn2 in P19 embryonal carcinoma stem 
cells. P19 cells are pluripotent embryonal carcinoma cells that maintain their phenotype when 
cultured in the presence of serum. They were originally derived from post-implantation embryos 
(28), capturing a later developmental stage than mouse ES cells. P19 cells resemble epiblast stem 
cells, a primed state of pluripotency which shares several features with human ES cells (29-31). P19 
cells can be easily differentiated down the neuronal or cardiomyocyte lineages, and have been 
extensively studied over the last three decades. Our data indicate that Hmgn proteins are important 
for regulating the active epigenetic landscape and gene expression profile, and are required for stem 
cell self-renewal and the prevention of inappropropriate differentiation. 
  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/498733doi: bioRxiv preprint first posted online Dec. 17, 2018; 
5 
 
Materials and Methods 
Cell culture: Mouse embryonic carcinoma cell line, P19, was maintained in advanced DMEM/F12 
containing 10% NBCS and 1X GlutaMAX. Adherent neural induction was performed using the 
method of Nakayama et al. (32), which involved seeding cell onto laminin-coated culture dishes in 
neural induction media: DMEM/F12 containing sodium pyruvate and NEAA supplemented with 1 X 
N2 supplement, 200 mM L-glutamine, 500 nM retinoic acid, 10 ng/ml FGF8 and 10 µM DAPT.  
To derive neural stem cells, the adherent neural induction protocol was initiated, and after three 
days, cells were switched to gelatine-coated flasks in N2B27 medium containing 10 ng/ml  FGF2 and 
10 ng/ml EGF (33). Cells were passaged eight times before being assayed for NSC characteristics. To 
differentiate the parental NSCs, cells were plated on laminin-coated dishes in N2B27 without FGF 
and EGF, and assayed after four days.  
Signalling inhibition: Cells were seeded at a density of 2 x 105 cells/well in 6 well plates, allowed to 
attach overnight and then 10 µM inhibitor was added: XAV-939 for WNT inhibition (S1180-SEL 
Stratech), DAPT for Notch inhibition (D5942 Sigma-Aldrich), and SU-5402 for FGFR inhibition 
(SML0443 Sigma-Aldrich). RNA was collected after 24 hours. For immunofluorescence, cells were 
plated in the presence of WNT inhibitor and assayed 48 hours later.  
CRISPR mutagenesis: A dual CRISPR nickase strategy (34)  was used to generate frameshift 
mutations in exon I of Hmgn2 (supplementary figure S1). A plasmid expressing the nickase mutant 
Cas9D10A-T2A-EGFP was transfected alongside plasmids expressing two gRNAs targeting exon I and 
intron I of Hmgn2 (gRNA sequences listed in supplementary table 1). Clonal lines were screened for 
Hmgn2 protein expression by immunofluorescence and western blotting. PCR followed by TA cloning 
and sequencing was used to confirm mutagenesis of both alleles in each clonal line. Lines N2-a, N2-b 
and N2-c carry different genetic changes, and so are independent of each other. To generate 
frameshift mutations in exon I of Hmgn1,  a plasmid expressing wild type Cas9-T2A-EGFP was co-
transfected alongside two gRNA expression plasmids, one expressing targeting Hmgn1 and the other 
targeting Hypoxanthine Phosphoribosyltransferase 1 (Hprt). Selection with 10 μg/ml 6-thioguanine 
was used to isolate clonal lines with inactivating Hprt mutations, in order to enrich for cells in which 
active CRISPR-mediated mutagenesis had occurred. Lines lacking Hmgn1 expression were identified 
as above. Lines N1-a and N1-b were independently derived from separate transfections.  
Gene expression analysis:  cDNA synthesised from purified RNA using Superscript III (Life 
Technologies), and qRT-PCR was performed using  SYBR green Fast start universal master mix 
(Roche). The housekeeping gene Gpi1 was used as the normaliser in ΔΔCt calculations. qRT-PCR 
primers for Hmgn1 span the exon V-VI junction, and primers for Hmgn2 span the exon IV-V junction. 
Primer sequences are listed in supplementary table 1.  
Western blotting The Hmgn1 and Hmgn2 antibodies were raised in rabbit against the C-terminal 
peptides NQSPASEEEKEAKSD and KTDQAQKAEGAGDAK, respectively, and affinity purified 
(Eurogentec). For western blotting, whole cell lysates were run on 15% SDS-PAGE gels, blotted onto 
PVDF and membranes probed with the relevant antibodies.  
Immunofluorescence: Cells were fixed with 4% PFA for 30 mins, permeabilised for 10 min with 0.1% 
PBS-triton X-100, washed with 20 mM PBS-glycine and blocked with 5% horse serum in 0.5% PBS-
triton X-100. Primary antibodies from Abcam were against Oct4 (Ab19857), Nanog (Ab80892), Ssea1 
(Ab16285), Gata4 (Ab84593), Nestin (Ab6142), βIII tubulin (Ab18207). Secondary antibodies were 
from Thermo Fisher Scientific (A21206, A11037, A11020). Images shown are representative of the 
whole slide.  
Chromatin immunoprecipitation (ChIP): Adherent cells were cross-linked in DMEM/F12 without 
serum for 5 min with 0.5% formaldehyde. ChIP was performed as described in (20). Briefly, for each 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/498733doi: bioRxiv preprint first posted online Dec. 17, 2018; 
6 
 
chromatin immunoprecipitation (IP) reaction, 5 µg of chromatin and 50 µl of magnetic DYNA beads-
Protein A (10002D Thermo Fisher Scientific) were used. Magnetic beads were blocked with 0.5% BSA 
prior to incubating with 2-3 µl of antibody in 200 µl of blocking buffer. Antibodies were from 
Millipore: H3K4me3 (07-433), H3K27me3 (07-449), H3 CT pan (07-690), H3K27ac (07-360), H3K4me1 
(07-436) or Abcam: H3122ac (ab33309). qPCR reactions contained 2% of IP DNA or 0.5 ng of input 
DNA. Primer sequences and locations relative to each transcription start site (TSS) are listed in 
supplementary table 1. The ratio of the PCR readings in IP vs. input DNAs (Ct) were calculated and 
converted to fold enrichments. The average fold enrichment for H3 across all primer sets tested was 
used to normalise the data for all ChIP reactions, which controls for small differences in chromatin 
concentration between samples.  
For ChIP-seq, libraries were prepared with the NEB ultra DNA library prep kit and single-end 
sequencing to 76 bp read length was carried out by the University of Glasgow Polyomics facility. 
Unfiltered reads from FASTQ files were aligned to reference genome NCBI build 37 mm9 using 
Bowtie (35); reads aligning to more than three positions and duplicate reads were discarded. 
Statistically enriched regions compared to a background control (peak finding) were identified using 
MACS  (36) with parameters p = 1e-3; bandwidth = 200; genome = mm9; fold enrichment = 10,30; 
and input control was used as a background. 
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Results 
Generation of Hmgn2 and Hmgn2 knockout cell lines 
CRISPR mutagenesis (34) was used to create clonal derivatives of P19 embryonal carcinoma cells in 
which Hmgn1 or Hmgn2 protein expression was abolished (supplementary figure S1). Two 
independent lines show complete loss of Hmgn1 expression: N1-a and N1-b (Figure 1a).  Control line 
CON-b went through the same process but Hmgn1 was not targeted and no loss of Hmgn1 protein is 
observed. Three independent lines show complete loss of protein expression: N2-a, N2-b and N2-c 
(Figure 1b). Control line CON-a was generated at the same time but has no mutagenesis of the 
Hmgn2 alleles.  
Immunofluorescence confirmed the loss of Hmgn1 and Hmgn2 protein in all cells in their respective 
knockout lines (supplementary figure S2). Quantitative RT-PCR revealed that Hmgn1 and Hmgn2 
transcript levels are significantly reduced in the knock-out cell lines, indicative of either a change in 
splicing preferences and/or a reduction in transcript stability (Figure 1c). The level of the Hmgn2 
transcript is increased by three fold in the Hmgn1 mutant line N1a (Figure 1c), but no corresponding 
increase in Hmgn2 protein is observed (Figure 1b). No other reciprocal changes in Hmgn1 or Hmgn2 
expression were observed in the other knockout or control lines (Figure 1a-c). 
 
Hmgn knockout cells have reduced expression of pluripotency markers 
P19 cells have lost the capacity of spontaneously differentiate, despite their teratocarcinoma origin, 
and can be propagated indefinitely in serum-containing medium as mostly pure cultures of 
undifferentiated cells.  Parental P19 cells are morphologically homogeneous and grow as discrete 
colonies. We observed that the loss of Hmgn1 or Hmgn2 expression considerably alters the cellular 
morphology and organisation of P19 cultures (supplementary figure S3). Fewer discrete colonies are 
observed, with a high proportion of Hmgn-knockout cells growing outside of normal colony 
boundaries. Many of these cells exhibit an extended cytoplasm and resemble differentiated cells, 
such as endothelial flat cells (37). Some cells have long processes that connect with other cells 
(supplementary figure S3).  
We hypothesised that these changes in cell morphology in the Hmgn knockout populations could 
reflect an increased propensity to differentiate. In order to investigate this further, the expression of 
self-renewal markers was assayed by immunofluorescence and qRT-PCR. The core pluripotency 
transcription factor Nanog is highly expressed in naïve pluripotent cells and is down-regulated upon 
lineage-priming (29,30). In the Hmgn knockout lines N1-b, N2-a and N2-c, Nanog mRNA expression is 
reduced by 3-10 fold relative to parental P19 cells (Figure 2a). By immunofluorescence, it can be 
seen that Nanog protein is heterogeneously expressed by parental and CON-a cells, with brighter 
cells (arrows) and paler cells (arrow heads) present in the same colony (Figure 2c). This is in 
agreement with previous reports suggesting that heterogeneity in Nanog production is related to 
diverse differentiation potentials among a polypopulation of pluripotent cells (38). Notably, Nanog 
protein expression is reduced in all the Hmgn1 and Hmgn2-knockout cultures (Figure 2c). Most of 
the Hmgn1 and Hmgn2 knockout cells have little or no Nanog expression, although a minor subset of 
cells retain modest Nanog expression. A reduction in Nanog protein in N2-b and N2-c cell lines was 
also observed by western blotting (Figure 2b).  
Stage-specific embryonic antigen 1 (Ssea1) plays a role in cell adhesion and migration in the pre-
implantation embryo, is widely used as a pluripotency marker in mouse ESCs, and is also expressed 
in embryonal carcinoma cells, including P19 cells (Figure 2d) (39). The majority of Hmgn-knockout 
cells lose expression of this pluripotency marker, especially those that grow beyond normal colony 
boundaries (arrow heads, Figure 2d). A subset of Hmgn-knockout cells growing in clusters retain 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/498733doi: bioRxiv preprint first posted online Dec. 17, 2018; 
8 
 
modest Ssea1 expression (arrows), which is lower than that seen in parental, CON-a and CON-b 
cultures. 
Oct4 is a transcription factor that is highly expressed in undifferentiated pluripotent stem cells. It is 
has also been shown to be retained in the first stages of ESC differentiation (40). Oct4 mRNA levels 
are similar across all the Hmgn knockout lines except N1-b, in which it is decreased by 40% (Figure 
2a). This is consistent with immunofluorescence data (Figure 2e). In the parental cells, Oct4 is 
homogeneously distributed along all cell lines and most of the cells show equivalent fluorescence 
intensity. In most of the Hmgn knockout cells, Oct4 expression in unchanged. However, some cells 
growing beyond colony boundaries are completely devoid of Oct4, especially in N1-b cultures (Figure 
2e, arrow heads).   
Sox2 has a similar expression pattern to Oct4 in the different pluripotency states and during early 
ESC differentiation (40), and is also expressed in neural stem cells. Sox2 mRNA expression is not 
altered in the Hmgn2 knockout lines, although its expression is increased in N1-a cells and decreased 
in N1-b cells (Figure 2a).  
Taken together, the reduction in Ssea1 and Nanog protein levels suggest that the maintenance of 
self-renewal and pluripotency are compromised in Hmgn-knockout cultures, even though the cell 
lines can still be propagated indefinitely.  
 
Hmgn knockout cells show increased spontaneous neuronal differentiation 
To investigate whether Hmgn knockout cells show increased levels of spontaneous differentiation in 
undifferentiated culture conditions, the expression of neuronal, endodermal and mesoderm markers 
was examined. βIII tubulin immunostaining was performed to detect differentiation down the 
neuronal lineage (Figure 3a). Strikingly, 24 hours after seeding the cells at low density, all five Hmgn 
knockout lines showed increased formation of βIII tubulin-positive cells with extended processes, a 
phenotype that is typical of immature neuronal cells. This contrast strongly with the low frequency 
of βIII tubulin-positive cells that are typically observed in the control cultures (Figure 3a). At 48 hours 
after seeding, extensive networks of neurites are visible in lines N1-a, N2-a, N2-b and N2-c (Figure 
3a). βIII tubulin mRNA levels show an increase of 2 – 2.6 fold in N1-a, N2-b and N2-c cells (Figure 3b) 
Nestin is an intermediate filament that is as a classical marker of neural stem cells.  P19 
undifferentiated cells express Nestin at basal levels (41). Nestin mRNA expression is increased by 3 
to 9 fold in N1-a, N1-b and N2-a cells (Figure 3b). Consistent with this, immunofluorescence shows 
that Nestin protein levels are somewhat higher in the Hmgn knockout cultures than in the control 
lines, particularly in the cells growing in three dimensional clusters (supplementary figure S4, part a, 
arrows).  
Neurog1 and Ascl1 are pro-neural transcription factors that play important roles in driving neuronal 
differentiation (42). Consistent with the increased spontaneous neuronal differentiation of Hmgn-
knockout cells, Neurog1 and Ascl1 are upregulated in most of the Hmgn-knockout lines when 
compared with parental cells (Figure 3c). Neurog1 transcription is increased by 5 to 25 fold in 
Hmgn1-knockout and Hmgn2-knockout lines, and Ascl1 is increased by 8 to 18 fold in Hmgn2-
knockout cells and 67 fold in N1-a cells when compared with the parental cells (Figure 3b).  
P19 cells can be differentiated down the mesodermal lineage into cardiomyocytes in the presence of 
DMSO or other inducers (43). To test whether Hmgn-knockout cells spontaneously differentiate 
down this lineage, Gata4 and Brachyury  (Bry or T) expression was analysed. Gata4 and Brachyury 
are typically regarded as mesodermal and/or endodermal markers. In differentiating P19 cells, 
Brachyury  is an early marker of mesodermal differentiation, whereas Gata4 is expressed slightly 
later, in cardiomyoblasts, where it regulates cardiomyocyte differentiation (44). We find that Gata4 
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transcript levels are increased by around 5 fold in the Hmgn1 knockout lines N1-a and N1-b, but are 
only increased by 2.5 fold in one of the Hmgn2 knockout lines, N2-a (Figure 3d). 
Immunofluorescence reveals very few Gata4-positive cells are across all the control and Hmgn 
knockout cell lines (supplementary figure S4b). However, a subset of Gata4-positive cells are 
observed in line N1-b (Figure S4b, arrows). Conversely, Brachyury transcript levels are decreased in 
three of the Hmgn knockout cell lines (N1-b, N2-a and N2-c) (Figure 3d). Although the increase in 
Gata4 expression might indicate initiation of cardiogenesis, this is not consistent with the reduction 
in Brachyury expression. Therefore, this data may be more consistent with a general loss of control 
of self-renewal in the Hmgn1 knockout cells.  
Taken together, this data shows that the loss of either Hmgn1 or Hmgn2 compromises the self-
renewal of pluripotent embryonal carcinoma cells, disrupts the gene expression profile, and leads to 
the initiation of differentiation programs that are mainly, but not exclusively, towards neural 
lineages.  
 
Spontaneous neuronal differentiation is not driven by increased autocrine signalling 
The main signalling pathways involved in neuronal differentiation are Notch signalling, which 
promotes survival and self-renewal of NS cells (45), FGF signalling, which is important for both NS 
cell proliferation and differentiation (46), and WNT signalling, which can either promote self-renewal 
or neuronal specification, depending on the developmental stage (47). We hypothesised that these 
pathways may be dysregulated in the Hmgn knockout cells, leading to the increased levels of 
spontaneous neuronal differentiation that were observed.  
To test this hypothesis, three known targets of these pathways were studied, Axin2, Fgf4 and Hes5. 
Activation of WNT signalling promotes a negative regulatory feedback loop, in which the expression 
of the canonical WNT inhibitor Axin2 is up-regulated (47). FGF signalling activates transcription of 
Fgf4, which promotes neuronal differentiation and is detected in the early stages of P19 neuronal 
differentiation (46). Hes5 is a basic helix loop helix transcription factor whose transcription is 
activated by Notch signalling. It represses pro-neuronal transcription factor gene expression and 
thus prevents the differentiation of NS cells (48). 
The expression of these target genes in the Hmgn2 knockout lines was evaluated by qRT-PCR (Figure 
4a). No significant changes in expression of Hes5, Axin2 or Fgf4 were observed in the Hmgn2 
knockout cell lines, indicating that the activity of these signalling pathways is not altered. To confirm 
that these pathways are active in the P19 lines, cells were treated with the Notch signalling inhibitor 
DAPT, the FGF receptor inhibitor Su05402, or the WNT pathway inhibitor XAV-939.  In both control 
and Hmgn2 knockout cell lines, the signalling inhibitors reduced expression of the effector genes 
Axin2, Fgf4 and Hes5 as expected (Figure 4a). 
Although Notch, FGF and WNT signalling does not appear to be increased in Hmgn2 knockout cells 
relative to the parental cells, it is possible that the knockout cells respond differently to the signalling 
events that are active. For example, changes in chromatin structure could mean that target genes 
are more or less responsive to a given level of signalling.  Therefore, we investigated the effects of 
inhibiting these signalling pathways on gene expression and cellular phenotype. As Nanog 
expression is reduced in several of the Hmgn knockout lines, we investigated whether its expression 
is altered following treatment with signalling inhibitors. It can be seen that the profile of changes in 
Nanog expression is the same in the Hmgn2 knockout lines as it is in the control lines (Figure 4b). 
Specifically, Nanog expression is reduced following treatment with the WNT inhibitor, unchanged 
following Notch inhibitor treatment, and increased after treatment with the FGF inhibitor.  We 
previously showed that  Neurog1 expression is increased in Hmgn2 knockout lines (Figure 3c). 
Treatment with signalling inhibitors has similar effects in Neurog1 expression in both the knockout 
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and the control lines: Neurog1 expression is unchanged when WNT signalling is inhibited, slightly 
increased (up to 3 fold) when Notch signalling is inhibited, and increased by 7 – 13 fold when FGF 
signalling is inhibited (Figure 4b).  
Finally, immunofluorescence was performed to investigate whether the proportion of neuronal cells 
was altered following inhibition of WNT signalling. It can be seen that the WNT signalling inhibitor 
does not substantially reduce the number of neuronal cells in N2-b and N2-c populations (Figure 4c). 
Taken together, this data indicates that the autocrine WNT, FGF and Notch signalling pathways are 
not enhanced in Hmgn2 knockout cells, and that the increased spontaneous neuronal differentiation 
does not appear to be driven by these signalling pathways.  
 
Induced neuronal differentiation proceeds normally in Hmgn1 and Hmgn2-knockout cells  
In order to investigate whether Hmgn knockout cells show an increased ability to differentiate into 
neurons following induction stimuli, a well-established P19 neuronal induction protocol was used 
(32). This includes the stimulation of the cells with retinoic acid and fibroblast growth factor 8 (FGF-
8), and the use of the Notch pathway inhibitor DAPT to stimulate cell cycle exit. Expression of 
neuronal lineage genes including Nestin, Neurog1 and Ascl1 is strongly induced by day 3, and 
complex networks of neurites are apparent by day 4 (Figure 5a and b, supplementary figure S5) (32).  
Hmgn1 and Hmgn2 knockout cells were assayed at several time points in order to assess both 
differentiation efficiency and timing. Expression of the pro-neural transcription factor Neurog1 was 
induced by up to 1500 fold, and Ascl1 was induced by up to 450 fold during the first four days, but 
no significant differences were observed between the Hmgn knockout cells and the control lines 
(Figure 5a and supplementary figure S5). Similarly, no significant differences were observed in the 
timing or level of induction of Nestin, nor was the loss of Nanog expression during the differentiation 
process altered significantly (supplementary figure S5).  
Immunofluorescence for the neuronal marker βIII tubulin was performed on both Hmgn1 and 
Hmgn2 knockout cells on day 4 after induction, but no significant differences can be observed in the 
level of marker expression or cell morphology between parental and knockout cells (Figure 5b). 
Interestingly, a sub-population of Gata4-positive cells was observed in N1-a, N1-b and N2-a cultures, 
which may indicate initiation of endodermal or mesodermal pathways (Figure 5b). 
These results indicate that most of the Hmgn-knockout cells respond normally to neuronal induction 
cues, and are capable of generating neuronal cells with similar timing and efficiency to the parental 
and control lines.  
 
Neural stem cells lacking Hmgn1 or Hmgn2 show loss of NSC self-renewal 
Although the direct neuronal induction protocol described above is rapid and highly efficient, no glial 
cells are produced, and the formation of large three-dimensional clusters of cells at later time points 
makes further analysis more challenging (K.L. West, unpublished). To circumvent these issues, we 
derived neural stem-like cells from the control and Hmgn-knockout P19 cultures (33). NSCs derived 
from the parental P19 cells can be maintained for many passages, express high levels of Nestin and 
have a bipolar morphology that is typical of NSCs (PAR-NSC, Figure 6a). Parental P19 NSCs can also 
be differentiated into mixed cultures of neurons and glia upon removal of the growth factors EGF 
and FGF (PAR-diff, Figure 6c).  
Immunostaining of Hmgn-knockout cultures does not reveal any substantial differences in Nestin 
expression compared to the parental NSC cultures (Figure 6a). However, higher numbers of βIII-
tubulin-positive cells with extended processes are apparent in both Hmgn1- and Hmgn2-knockout 
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cultures (Figure 6b). At the mRNA level, neither Nestin nor βIII-tubulin expression is consistently 
altered in the Hmgn-knockout cells, which may indicate that βIII-tubulin protein production is 
regulated post-transcription in these cells (Figure 6c).  
Consistent with the increased numbers of neuronal cells detected by immunofluorescence, mRNA 
expression of the pro-neural transcription factor Neurog1 is increased by 10-44 fold in NSCs from 
N1-1, N2-a, N2-b and N2-c cells compared to the parental NSCs (Figure 6c). This increase is 
comparable to the 23 fold increase observed when parental NSCs differentiate into neuronal 
cultures (PAR-NSC versus PAR-diff, Figure 6c). Similarly, Oct4 expression is increased by 15 – 89 fold 
in all the Hmgn1- and Hmgn2-knockout NSCs compared to the control NSCs. This is comparable to 
the 18 fold increase  in Oct4 expression that is observed when parental NSCs differentiate into 
neuronal cultures (Figure 6c). However, expression of neuronal marker Map2 is not consistently 
altered in Hmgn knockout cultures compared to the parental and control NSCs.  
These data indicate that Hmgn1 and Hmgn2 play roles in maintaining the self-renewal of NSCs 
derived from P19 cells. The loss of either variant leads to spontaneous neuronal differentiation, with 
increased Neurog1 expression and production of βIII-tubulin-positive cells. 
 
Loss of Hmgn2 affects the profile of active histone modifications 
The data presented earlier shows that loss of Hmgn1 or Hmgn2 in undifferentiated P19 cells affects 
the expression of the pluripotency gene Nanog, the pro-neural genes Neurog1 and Ascl1, and the 
endodermal/mesodermal markers Gata4 and Brachyury. As Hmgn proteins play several roles in 
regulating chromatin structure, we first examined publically available ChIP-seq data from mouse 
ESCs to determine the chromatin structure of these genes (Figure 7c, supplementary figure S6, and 
data not shown). As expected, the highly expressed Nanog and Oct4 genes have high levels of the 
active mark H3K4me3 in the vicinity of their TSS, and negligible levels of the repressive mark 
H3K27me3. Notably, Neurog1, Ascl1, Gata4 and Brachyury have moderate levels of H3K4me3 but 
also have substantial levels of H3K27me3. This “bivalent” pattern is typical of poised stem cell genes 
with low levels of expression, which can be upregulated or silenced as the stem cells differentiate 
(2).  
To investigate whether Hmgn1 or Hmgn2 bind preferentially to the promoters of these genes, 
chromatin immunoprecipitation followed by qPCR was performed. Between one and four primer 
sets were designed for each gene locus, using the publically available H3K4me3 data from mouse ES 
cells as a guide. Single primer sets for Neurog1, Ascl1, and Bry target the peak of H3K4me3 nearest 
the TSS of each gene. Binding at the Oct4 and Nanog gene loci was assayed using several primer sets 
that encompass 2-3 kb surrounding the TSS. The locations of the primers relative to each TSS are 
illustrated in Figures 7c and S6.  
The ChIP data shows that Hmgn1 and Hmgn2 are bound at all the active and poised genes tested. 
Occupancy varies by less than two fold between different genes, with slightly higher occupancy at 
the Nanog gene locus (Figure 7a and b). In the Hmgn1 knockout lines, Hmgn1 signals are reduced by 
80% and 95% in the N1a and N1b lines, respectively. Conversely, Hmgn2 signals are reduced by 80% 
on average in the Hmgn2 knockout lines, N2-a, N2-b and N2-c. These data confirm the specificity of 
the Hmgn1 and Hmgn2 ChIP assays, and show that these proteins occupy the regulatory regions of 
both active pluripotency genes and poised/bivalent lineage-specific genes in undifferentiated P19 
cells.  
In order to investigate whether Hmgn2 binding is particularly enriched at these TSS regions 
compared to other regions of the genome, ChIP-seq was performed in both undifferentiated P19 
cells and P19 cells after three days of induced neuronal differentiation (Figure 7c and supplementary 
figure S6). The active marks H3K27ac and H3K4me1 were also mapped in order to validate the ChIP 
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assay and illustrate the chromatin landscape of undifferentiated and day 3 neuronal P19 populations 
(supplementary figure S6). For example, H3K27ac is enriched upstream of the Oct4 gene in 
undifferentiated cells, but this is lost in the day 3 neuronal cells when Oct4 is repressed. Conversely, 
H3K27ac is absent from the Ascl1 locus in undifferentiated cells, but increased in the day 3 neuronal 
cells when the gene is expressed. The H3K27ac and H3K4me1 profiles for undifferentiated P19 cells 
correspond closely to publically available datasets for undifferentiated mouse ES cells 
(supplementary figure S6).  
The Hmgn2 ChIP-seq binding profiles indicate that Hmgn2 is not highly enriched at active gene 
promoters, either in undifferentiated or day 3 neuronal cells, but instead is found at similar levels 
throughout the genome (Figure 7c and supplementary figure S6). In general, the profile of Hmgn2 
binding tends to follow that of H3.  Peak calling software identified 1,862 Hmgn2 peaks in 
undifferentiated cells. For example, there is a Hmgn2 peak in the Nanog promoter in 
undifferentiated cells (Figure 7c). However, only 8% of these Hmgn2 peaks overlap with TSSs or 
putative enhancers.  
In order to investigate whether loss of Hmgn2 protein affects histone modifications, ChIP-PCR was 
performed in undifferentiated parental, N2-b and N2-c cells (Figure 8). At the highly expressed 
pluripotency genes Oct4 and Nanog, loss of Hmgn2 leads to a loss of active histone marks associated 
with promoter and enhancer activity. Specifically, the promoter-associated marks H3K9ac and 
H3K4me3 are reduced at both genes in both Hmgn2 knockout lines, with the reduction in H3K9ac 
being more substantial (Figure 8a and b).  The enhancer-associated marks H3K27ac and H3K122ac 
are more highly enriched at the Oct4 locus compared to Nanog; both of these modifications are 
reduced in the Hmgn2 knockout cells, although the reduction in H3K27ac levels is greater (Figure 8d 
and f). These reductions in active histone modifications do not appear to have a strong influence on 
expression of the genes, however, as Oct4 expression is unchanged in the N2-b and N2-c lines, 
whereas Nanog levels are decreased in N2-c cells. Oct4 and Nanog have negligible levels of the 
repressive mark H3K27me3 in parental cells, and this is not altered in the Hmgn2-knockout lines 
(Figure 8c). 
The bivalent endodermal/mesodermal marker genes, Gata4 and Brachyury, lose the active promoter 
marks H3K4me3 and H3K9ac in Hmgn2-knockout cells, but retain the repressive H3K27me3 mark 
(Figure 8a, b, c). These changes indicate a switch from bivalency to a more repressive chromatin 
state. This does not appear to impact Gata4 expression, which is unchanged in the N2-b and N2-c 
cells. However, the reduction in active marks is greater at the Brachyury locus, which is consistent 
with the observed decrease in Brachyury expression in these lines (Figure 3d).  
Conversely, pro-neural genes whose expression increases in Hmgn2 null cells do not lose their 
bivalent signature. H3K9ac is unchanged at either Neurog1 or Ascl1, and H3K4me3 at Ascl1 is 
increased in N2-b cells and decreased in N2-c cells. No changes in H3K27me3 were observed either 
locus (Figure 8a,b, c).  
In order to extend the observations made at individual genomic locations, the global levels of several 
active histone modifications were investigated in Hmgn1 and Hmgn2 knockout cells (supplementary 
figure S7). Consistent with the ChIP data, global levels of H3K4me3 are reduced by 64% in N2-b cells 
compared to control CON-a cells, but this reduction is not observed in the other Hmgn knockout 
lines tested. Both the N2-a and N2-b knockout lines show a significant reduction in global H3K9ac 
levels, consistent with the ChIP data, but this is not observed in the Hmgn1 knockout lines.  The 
greatest reduction was observed with H3K27ac, which is significantly reduced in both Hmgn1 (N1-a) 
and Hmgn2 (N2-b) knockout cells (supplementary figure S7).  
In summary, it is clear that loss of Hmgn2 can lead to reductions in the levels of active promoter and 
enhancer histone modifications at specific gene loci. The highly expressed pluripotency genes Oct4 
and Nanog show a reduction in active marks at promoters and enhancers. The poised 
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endodermal/mesodermal genes Gata4 and Brachyury switch from bivalency to a more repressive 
chromatin configuration, whereas the poised pro-neural genes Neurog1 and Ascl1 retain their 
bivalent state. Some, but not all, of these changes are reflected in the global levels of the 
modifications, with H3K27ac being most strongly reduced in both Hmgn1 and Hmgn2 knockout lines.  
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Discussion 
Hmgn proteins regulate the self-renewal of pluripotent and multipotent embryonal carcinoma 
cells 
Hmgn proteins are highly expressed during development and in differentiating cells, but are 
downregulated in mature tissues (15,22). In particular, high Hmgn expression has been observed in 
the neural stem/progenitor cells of the sub ventricular zone of the mouse brain, and the transit-
amplifying progenitor cells of hair follicle (3,22,25,26). A role for Hmgn proteins in regulating the self 
-renewal or differentiation of stem/progenitor cells is supported by the observation that 
downregulation of Hmgn expression is important for the differentiation of limb bud mesenchymal 
cells into chondrocytes in vitro (15,24).  
Here, we have studied the role of Hmgn1 and Hmgn2 in pluripotent embryonal carcinoma cells, and 
in neural stem cells derived from them. With both Hmgn1 and Hmgn2 knockout EC cells, we observe 
increases in spontaneous neuronal differentiation, which are accompanied by the loss of some 
pluripotency markers and increases in the expression of pro-neural transcription factors.  
Bright field microscopy and immunostaining revealed that Hmgn-knockout cells are morphologically 
heterogeneous and are less likely to grow in tight colonies,  resembling the differentiated cells in ESC 
cultures (37). A high proportion of Hmgn-knockout cells are devoid of the pluripotency markers 
Ssea1 and Nanog, as revealed by immunofluorescence. Nanog is one of several pluripotency-related 
transcription factors that are downregulated in the transition from naïve pluripotency to the primed 
state for differentiation (29,30). However, Nanog is known to be heterogeneously expressed in ESC 
and P19 cultures, and the low-Nanog cells show higher lineage-specific gene expression (38). 
Although the low-Nanog cells are more prone to differentiate, they have not abandoned 
pluripotency as they indefinitely self-renew and can generate daughter cells with higher Nanog 
levels (38). Therefore, it seems unlikely that the increased number of differentiated cells in the 
Hmgn knockout cultures is due solely to a reduction in Nanog expression.  
Expression of the transcription factors Oct4 and Sox2 is not altered by the loss of Hmgn1 or Hmgn2. 
Unlike Nanog, Oct4 and Sox2 are retained during the early stages of differentiation where they 
interact with different lineage-specific transcription factors to influence fate commitment (40). It is 
possible that some of the Oct4-positive cells in the Hmgn knockout cultures have abandoned 
pluripotency and initiated differentiation programs. 
Spontaneous differentiation of Hmgn-knockout cells down the neural lineage is evidenced by βIII-
tubulin immunostaining, although some Gata4-positive cells are also observed in some of the lines. 
Consistent with this, gene expression analyses show increased Neurog1 and Ascl1 expression in 
Hmgn1 and Hmgn2 knockout lines. The predominance of neuronal cells over other lineages is 
consistent with the default model of neural differentiation, which proposes that pluripotent 
embryonic stem cells commit to neural fates unless instructed otherwise (49). For example, ESCs 
start losing their identity upon withdrawal of the factors that maintain them in a pluripotent state, 
and they differentiate mostly into neural lineages (33). Neurog1 and Ascl1 are powerful pro-neural 
regulators whose overexpression can drive the neuronal differentiation of P19 cells and ES cells 
(50,51). It is possible that these two transcription factors are key contributors to the spontaneous 
neuronal differentiation observed in the Hmgn-knockout cells. 
Our observations contrast with previous work performed in mouse ES cells derived from Hmgn1-/- 
and Hmgn1-/-n2-/- mice, where ES cell pluripotency and self-renewal did not appear to be altered 
(3,12). It is unclear whether the differences are related to the transformed nature of the EC cells, or 
due to the growth media used, which may permit or restrict spontaneous differentiation depending 
on whether cells are cultured in the presence of serum or 2i inhibitors. It is also worth considering 
the different developmental stages from which ESCs and P19 cells were derived. ESCs capture the 
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naïve state of pluripotency from pre-implantation embryos, whereas epiblast stem cells represent a 
pluripotency state primed for differentiation (29-31). If this is valid for transformed cells, P19 cells 
that were derived from post-implantation embryos can immediately commit to differentiation, 
whereas ESCs first need to exit the naïve pluripotency stage so that they may respond to inductive 
cues (30).  Therefore, Hmgn proteins may not be relevant in the preservation of the naïve 
pluripotency; rather, these chromatin architectural proteins may be important for maintaining the 
primed cells unresponsive to misplaced inductive differentiation cues.  
To investigate whether the loss of self-renewal that we observed in the undifferentiated cultures 
was specific to pluripotent stem cells, we generated multipotent neural stem/progenitor cells from 
the control and Hmgn knockout cell lines. Notably, the gene expression profiles of the neural stem 
cell cultures were altered in Hmgn1 and Hmgn2 knockout cells, with substantial increases in Oct4 
and Neurog1 expression, and increased levels of βIII-tubulin – positive neuronal cells. Thus, the loss 
of control of self-renewal is not specific to pluripotent P19 cells, but is also apparent in P19-NSCs 
lacking Hmgn1 or Hmgn2. It has been previously demonstrated that Hmgn1-/- mice have fewer 
Nestin-positive cells in the sub-ventricular region of the brain (3), which is consistent with the 
hypothesis that self-renewal is compromised in neural stem/progenitor cells lacking Hmgn1 or 
Hmgn2. Our results complement a previous study that demonstrated a role for Hmgn proteins in 
regulating the differentiation of neural stem/progenitor cells (NPCs) (26). Overexpression of Hmgn 
proteins in NPCs, both in vivo and in vitro, was shown to promote astrocyte differentiation and 
inhibit neurogenesis, whereas knocking down Hmgn expression had the converse effect (26).  
 
Neuronal signalling pathways are not altered in Hmgn knockout EC cells 
The timing of differentiation is regulated by transcriptional switches that are driven by intrinsic or 
extrinsic signals. Three major pathways that regulate neuronal differentiation are Notch, FGF and 
WNT. Inhibitors were used in order to investigate whether changes in these signalling pathways are 
driving the differentiation of Hmgn knockout cells. Known target genes of these pathways, Axin, Fgf4 
and Hes5, are not significantly altered in the Hmgn knockout cells, and treatment with the inhibitors 
has similar effects on these target genes in both the control and the knockout cells, indicating that 
these pathways are operating normally in the Hmgn knockout cells.  
Notch signalling promotes self-renewal and survival of NS cells in early stages of development, 
whereas in later stages it favours glial versus neuronal fates (45). Inhibition of neuronal 
differentiation by the Notch pathway is mediated by its targets, Hes1 and Hes5, which suppress the 
expression of pro-neuronal transcription factors such as Neurog1, Neurog2 and Ascl1 (48). However, 
Notch is not relevant for pluripotency (52), which explains the observation that Nanog expression is 
not influenced by iNotch in any of the cell lines. Inhibition of Notch signalling led to a small increase 
in Neurog1 expression of up to 3 fold in both the control and the Hmgn2 knockout lines, indicating 
that Notch does not play a major role in preventing neuronal differentiation of P19 cells.  
FGF and WNT pathways establish a cross-talk to pattern the neural plate and influence cell fate (53). 
FGF signalling is used to derive and maintain the NS cells, but also to induce neuronal differentiation 
in vitro (46). Fgf4 stimulates FGF signalling in an autocrine manner, allowing embryonic pluripotent 
cells to commit to differentiation (54). In agreement, Nanog is upregulated in all P19 cell lines after 
inhibition of FGF signalling, suggesting that at least some of the cultured cells can revert to a more 
naïve pluripotency state under FGF signalling inhibition. The fact that interfering with FGF signalling 
has a comparable effect in all the cell lines, including higher pro-neural gene expression, suggest that 
the spontaneous neural differentiation of Hmgn2-knockout cells is not explained by changes in FGF 
signalling.    
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WNT signalling has also been reported to have dual roles during neuronal differentiation; in the 
expansion phase it promotes self-renewal of NS cells, but in the neurogenic phase it acts as an 
instructive pathway for neuronal differentiation by targeting the pro-neural transcription factor 
Neurog1 (47). WNT signalling also does not seem to be responsible for the neural differentiation of 
P19 cells after the loss of Hmgn2, as iWnt has little effect on pro-neural gene expression. In 
conclusion, it appears that none of the tested signalling pathways trigger differentiation of P19 cells 
after the loss of Hmgn2, as interfering with them does not re-establish lineage-specific gene 
expression to parental levels. These observations suggest that the loss of a major Hmgn variant is 
permissive for the initiation of differentiation following an intrinsic and cell-autonomous program. 
 
Hmgn proteins modulate the epigenetic landscape of EC cells 
The binding of Hmgn proteins to nucleosomes is known to be transient and dynamic (17). Here, 
ChIP-seq shows Hmgn2 is bound throughout the non-repetitive genome, and with no highly enriched 
peaks at transcription start sites or enhancers in pluripotent P19 cells and early neuronal cultures. Its 
binding profile is broadly similar to that of the core histone H3. Previous studies have indicated that 
Hmgn proteins are enriched at DHSs in some cell types but not in others, although it is not clear 
whether the different antibodies used have contributed to the apparent differences in binding 
profiles (3,9,12,15,16,18-20). It is conceivable that the accessibilities of specific Hmgn epitopes may 
vary, depending on the Hmgn protein conformation or its binding partners. We then performed 
more detailed chromatin analysis at three classes of genes expressed in pluripotent stem cells – 
pluripotency associated genes (Nanog, Oct4), bivalent endodermal/mesodermal lineage genes 
(Brachyury, Gata4) and bivalent pro-neural genes (Neurog1, Ascl1). The data confirm that both 
Hmgn1 and Hmgn2 are bound at the promoter regions of all three gene classes of gene.  
Chromatin immunoprecipitation assays show that loss of Hmgn2 leads to a reduction in the active 
histone modifications at the promoters and enhancers of these target genes. However, the extent of 
the changes and the impact on gene expression differs between each gene class. The levels of 
H3K4me3, H3K9ac, H3K27ac and H3K122ac are reduced at the pluripotency associated genes Nanog 
and Oct4; this corresponds to a reduction in Nanog expression, although Oct4 levels are unchanged. 
H3K4me3 and H3K9ac are reduced at the poised genes Gata4 and Brachyury, such that their bivalent 
chromatin state is switched to a more H3K27me3-dominant repressive chromatin configuration. 
However, this only appears to reduce Brachyury expression, as Gata4 expression is unchanged in 
these cell lines. Conversely, the pro-neural genes Neurog1 and Ascl1, whose expression is increased 
in the Hmgn knockout cells, show no changes in histone modifications and retain their bivalent 
status. Genome-wide studies would be required to investigate whether these trends are also found 
at other highly expressed and poised genes. However, it is clear that the loss of Hmgn2 significantly 
impacts the epigenetic landscape of P19 cells, leading to a reduction in active marks at specific gene 
loci. The data supports a role for Hmgn2 in maintaining the open chromatin conformation at gene 
regulatory elements in embryonic stem cells, thus supporting the chromatin plasticity that is 
required for self-renewal and pluripotency (1).  
Several previous studies have shown that Hmgn proteins directly influence the levels of histone H3 
modifications. Specifically, Hmgn1, Hmgn2 and Hmgn3a can stimulate the ability of PCAF to 
acetylate nucleosomal H3K14, with Hmgn2 showing the greatest effect (6,8,9). This activity is 
dependent on the C-terminal regulatory domain, and kinetic and structural data reveal that 
interaction of the Hmgn protein with the H3 N-terminal tail may make it a better substrate for 
histone acetylase activity (8,11).  Conversely, Hmgn proteins have been shown to inhibit 
phosphorylation of H3 at serine 10 and serine 28 (6,7). Further investigation is needed to determine 
whether Hmgn proteins can also influence the deposition or removal of H3K4 methylation.   
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Deng et al. have previously shown that loss of both Hmgn1 and Hmgn2 leads to increased levels of 
the repressive mark H3K27me3 around the Olig1 and Olig2 gene loci in mES cells (12). This is 
mediated by increased H1 binding in the absence of Hmgn proteins, leading to increased 
recruitment of the H3K27 methyltransferase, EZH2.  We do not observe increased H3K27me3 levels 
in P19 cells lacking a single Hmgn variant, possibly because levels of the remaining Hmgn variant are 
sufficient to prevent increased H1 binding.  
We conclude that the loss of Hmgn2 leads to a widespread reduction in the levels of active 
modifications at histone H3. However, the epigenetic changes at individual gene loci do not always 
match the changes in gene expression observed in these cells. Further work is required to determine 
whether other features such as nucleosome positioning, histone variant deposition or transcription 
factor recruitment are altered in the Hmgn knockout cells and could affect the transcriptional profile 
and cellular phenotype (10,13,14).  
The results of the present work demonstrate that the loss of Hmgn1 or Hmgn2 compromises the 
ability of embryonal carcinoma cells, and the NSCs derived from them, to self-renew accurately and 
maintain pluri/multipotency. As a consequence, a proportion of the cells exit pluri/multipotency and 
initiate differentiation programs. We show that the loss of Hmgn proteins disrupts the active 
modification landscape in pluripotent stem cells, which impacts the transcription of both 
pluripotency  genes and bivalently-marked differentiation factor genes. Our data is consistent with a 
growing consensus that Hmgn proteins do not act as specific regulators of gene expression, but fine-
tune a cell’s transcriptional profile by influencing the landscape of histone modifications and 
chromatin structure (3,12,19). We propose that Hmgn proteins contribute to chromatin plasticity in 
pluripotent stem cells, facilitating open chromatin states that are essential for maintaining self-
renewal and pluripotency.   
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Figure legends 
Figure 1 Generation of Hmgn1 and Hmgn2 knockout P19 lines 
Western blot analysis of (A) Hmgn1 and (B) Hmgn2 protein levels in clonal P19 lines; β-tubulin is 
shown as a loading control. (C) Hmgn1 and Hmgn2 mRNA expression as determined by qRT-PCR in 
control and Hmgn-knockout cells. The graph represents the average fold change relative to parental 
P19 cells. Error bars represent the SEM from 3-10 independent cultures. The statistical significance 
was calculated by ANOVA and Dunnett’s multiple comparison test (adjusted p value ***<0.0001). 
 
Figure 2 Expression of pluripotency markers in Hmgn knockout cells 
(A) Relative expression of the pluripotency transcription factors Oct4, Sox2, and Nanog as 
determined by qRT-PCR. The graphs show the fold change relative to parental P19 cells. Error bars 
represent the SEM from 3-10 independent cultures. The statistical significance was calculated by 
ANOVA and Dunnett’s multiple comparison test (adjusted p values *<0.05, **<0.01, ***<0.001). 
(B) Western blot analysis of Nanog protein levels in whole cell extracts from parental P19, N2-b and 
N2-c cells. H3 is shown as a loading control. The ratio of Nanog to H3, relative to that in parental 
cells, is shown below. 
(C-E) Immunofluorescence analysis of pluripotency marker expression. Parental, CON-a, and Hmgn-
knockout cells were fixed 24 h after seeding. DAPI was used to stain the nuclei (cyan). Scale bar 
indicates 50 µm. (C) Nanog immunostaining in green. Nanog levels are heterogeneous in all cell lines, 
as marked by  higher (arrows) and reduced (arrow heads) fluorescence intensity. (D) Ssea1 
immunostaining in red. Clustered Hmgn-knockout cells retain higher levels of Ssea1 (arrows) than 
the cells that grow spread outside the colonies (arrow heads). (E) Oct4 immunostaining in green. 
Arrowheads indicate cells with reduced Oct4 staining.  
 
Figure 3 Hmgn knockout cells show increased levels of spontaneous neuronal differentiation. 
(A) Immunofluorescence analysis of the neurofilament protein βIII-Tubulin (red). Parental, CON-a, 
and Hmgn-knockout cells were fixed 24hr and 48 hr after seeding. DAPI was used to stain the nuclei 
(cyan). Scale bar indicates 50 µm. 
(B) Relative mRNA expression of the neural-specific markers Nestin, βIII-tubulin and Map2, and (C) 
the lineage-specific transcription factors Neurog1, Ascl1, and (D) the endodermal/mesodermal 
markers Gata4, and Bry (T). N.D:  no data available. The graphs show the fold change relative to 
parental cells. Error bars represent the SEM from 3-10 independent cultures. The statistical 
significance was calculated by ANOVA and Dunnett’s multiple comparison test (adjusted p values 
*<0.05, **<0.01, ***<0.001). 
 
Figure 4: Inhibition of WNT, Notch or FGF signalling pathways does not alter the Hmgn2 knockout 
cell phenotype 
(A) Relative expression of the reporter genes for WNT (Axin2), Notch (Hes5) and FGF (Fgf-4) 
signalling pathway activity and (B) relative expression of Nanog and Neurog1 in parental, CON-a, and 
Hmgn2-KO cells, as determined by real time RT-PCR.  Expression levels of the reporter genes were 
assayed after 24 h of treatment with 10 µM of  the signalling pathway inhibitor: DAPT for Notch, SU-
5401 for FGFR, and XAV-939 for WNT. The graphs present the mean and s.d. of 3 independent cell 
cultures per cell line. In (A), expression is plotted relative to that in untreated parental cells. The 
Student’s T-test was used to test for significant differences between untreated parental and 
untreated control or knockout lines. * = P < 0.05. For each cell line in (B), expression in treated cells 
is plotted relative to that in untreated cells. The Student’s T-test was used to test for significant 
differences between untreated and treated cells of the same line. * = P < 0.05, ** = P < 0.01 (C) 
Immunofluorescence for βIII-tubulin expression in parental and Hmgn2 knockout cell lines plated in 
the presence or absence of WNT inhibitor and assayed after 48 hrs.  
 
Figure 5: Induced neuronal differentiation is not altered in Hmgn2 knockout cells. 
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(A) Relative mRNA expression of the Neurog1 and Ascl1 genes in parental, CON-a, and N2-b and N2-c 
cells induced to differentiate along the neuronal lineage. A total of four time points during the protocol 
were evaluated (1-4 days after induction), together with the undifferentiated cultures (day 0). 
Expression is plotted relative to that in undifferentiated, untreated parental P19 cells. The data is 
representative of two independent biological replicates. (C) Immunofluorescence for βIII tubulin, 
Gata4 and DAPI at day 4 in parental, N1-a, N1-b, N2-b and N2-c cells. Scale bar indicates 50 µm. 
 
Figure 6: Neural stem cells derived from cells lacking Hmgn1 or Hmgn2 show loss of NSC identity 
Immunostaining for (A) Nestin and (B) βIII tubulin in NSCs derived from parental P19 cells, Hmgn1 
and Hmgn2 knockout lines. Scale bar indicates 50 µm. (C) Relative mRNA expression in NSCs derived 
from parental P19 cells, CON-a cells, and Hmgn1 and Hmgn2 knockout lines. Expression in parental 
NSCs that were induced to differentiate down the neuronal lineage by removal of growth factors is 
also shown. Expression is normalised to that of Gpi1, and is plotted relative to that in parental NSCs. 
Error bars represent the s.d. from technical qRT-PCR triplicates. Data is representative of two 
independent NSC derivation experiments.  
 
Figure 7: Hmgn1 and Hmgn2 are not highly enriched at active gene promoters.  
ChIP-PCR assays in parental P19, control CON-a, N1-a, N1-b, N2-a and N2-b cell lines. Enrichment of 
Hmgn1 (A) or Hmgn2 (B) at each primer set was normalised to the average H3 signal from all primer 
sets. The graphs present the mean and s.d. of technical qPCR triplicates from the same IP reaction. 
Data is representative of 2-3 independent biological replicates. 
(C) ChIP-seq for Hmgn2 and H3 was performed in undifferentiated and day 3 neuronal induced P19 
cells. Reads were aligned to the mm9 mouse genome and regions surrounding the Nanog and 
Neurog1 loci are shown.  Peaks revealed by MACS peak calling software for Hmgn2 and H3 are 
shown as red blocks below the relevant signal track. Positions of the primer sets used for ChIP are 
indicated. Data for H3K4me3 and H3K27me3 in mouse ES Bruce4 cells was obtained from the UCSC 
genome browser and was generated by the Ren lab as part of the ENCODE/LICR project 
(http://genome.ucsc.edu) (55,56). TSSs for the indicated genes were confirmed by comparison with 
hCAGE data from the FANTOM5 project (57). Y-axis maxima are 0.62 for all H3 and Hmgn2 tracks, 21 
for H3K4me3 and 3.5 for H3K27me3. 
 
Figure 8: Hmgn2-Ko cells show a reduction in active histone H3 modifications at bivalent and 
active gene loci. 
ChIP-PCR assays in parental P19, N2-b and N2-c cell lines for H3K4me3 (A) and H3K9ac (B), 
H3K27me3 (C), H3K27ac (D), H3 (E) and H3K122ac (F). The enrichment of each modification was 
normalised to the average H3 signal from all primer sets. The graphs present the mean and s.d. of 
technical triplicates from the same IP reaction. Data is representative of 2-3 independent biological 
replicates.  
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